Epidemiology and Antifungal Susceptibility of BloodstreamCandidaIsolates in Quebec: Report on 453 Cases between 2003 and 2005
Author(s) -
G. StGermain,
Michél Laverdière,
René Pelletier,
Pierre René,
Anne–Marie Bourgault,
Claude Lemieux,
Michael Libman
Publication year - 2007
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2008/634046
Subject(s) - fluconazole , voriconazole , itraconazole , candida parapsilosis , caspofungin , fungemia , microbiology and biotechnology , candida tropicalis , candida glabrata , candida krusei , population , posaconazole , candida albicans , medicine , amphotericin b , biology , antifungal , environmental health
Between May 2003 and April 2005, a population-based surveillance of Candida bloodstream infections was conducted in Quebec. A total of 453 episodes of candidemia (464 yeast isolates) from 54 participating hospitals were studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom